Plain-English translation of NCT05236686 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a surgical procedure called hepato-celiac lymphadenectomy, which removes lymph nodes in the upper abdomen that may contain ovarian cancer. The study includes women with advanced ovarian cancer at diagnosis or cancer that has come back after treatment. Researchers want to see if removing these lymph nodes safely improves how long patients survive.
When ovarian cancer spreads to lymph nodes in the upper abdomen, doctors aren't sure whether removing these nodes during surgery helps patients live longer or better. This trial is designed to find out if this surgical approach is safe and effective for women with this type of advanced cancer.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo the hepato-celiac lymphadenectomy procedure, which involves surgery to remove lymph nodes in the upper abdomen along with treatment of your ovarian cancer. You will be followed by the research team after surgery to monitor your safety and how well the treatment works. The trial involves multiple visits to track your health and gather information about how you are doing over time.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Sponsor
Shanghai Gynecologic Oncology Group
Collaborators
Fudan University
Enrollment target
~94 participants
Started
February 2022
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Sex
Female only
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Libing Xiang
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.